Articles

Poll

Podcasts

Slideshows

Videos

Sleep

On the HCPLive sleep page, resources on the topics of medical news and expert insight into sleep medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on sleep apnea, insomnia, narcolepsy, and more.

At SLEEP 2025, HCPLive spoke to Strollo about the phase 3 SynAIRgy trial which evaluated AD109, a first-in-class, once-daily oral neuromuscular modulator, for OSA.

AD109 Improves OSA in Phase 3 SynAIRgy Trial, With Patrick Strollo, MD

At SLEEP 2025, Cassiere discussed how pulse oximetry inaccuracies among patients with darker skin tones may lead to underdiagnosis or misclassification of sleep apnea severity.

Racial Bias in Pulse Oximetry Skews Sleep Apnea Diagnoses, Warns Hugh Cassiere, MD

Findings highlight an increased risk of MASLD, heart failure, type 2 diabetes, and other cardiometabolic diseases following cycles of weight loss and regain.

Weight Cycling Increases Risk of MASLD, Other Cardiometabolic Diseases

At SLEEP 2025, Kancherla highlights diagnostic dilemmas, treatment gaps, and the need for pediatric criteria when managing obstructive sleep apnea in teens.


Adolescent OSA Management Needs Guideline Update, Says Binal Kancherla, MD

At SLEEP 2025, Kancherla emphasized the importance of using pediatric criteria to manage OSA in adolescents, warning that adult standards may overlook key developmental factors.


Why Teens with OSA Shouldn’t Be Treated Like Adults, with Binal Kancherla, MD

At SLEEP 2025, Danny Eckert, PhD, discussed new drug therapies for OSA, including tirzepatide, AD109, potassium channel blockers, and acetazolamide.


Latest Pharmacotherapy Developments for Sleep Apnea, with Danny Eckert, PhD

Treating Insomnia First May Be Key to Effective PTSD Therapy, with Peter Colvonen, PhD

New research has indicated that glucagon-like peptide-1 receptor agonists result in lower all-cause mortality and risk of cardiovascular events in patients with concurrent sleep apnea and type 2 diabetes.

Study Highlights Cardiopulmonary Benefits of GLP-1 RAs in Patients with Diabetes, OSA

Prevot describes her research exploring the relationship between OSA severity and abdominal obesity metrics as well as changes in both metrics following CPAP.

Using AI to Explore CPAP’s Impact on Abdominal Obesity in OSA, with Jennifer Prevot, MD

A post-hoc analysis of SURMOUNT-OSA highlights tirzepatide’s consistent benefit across all baseline OSA severity groups.

Obstructive Sleep Apnea